Adoptive immunotherapy: New ways to skin the cat?

Clinical Immunology

Volumn 117, Issue 2, 2005, Pages 101-103

  Milone, Michael C ^a   June, Carl H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

CAT; CELL PROLIFERATION; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNOTHERAPY; NONHUMAN; NOTE; PASSIVE IMMUNIZATION; PATIENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR CELL;

ANIMALS; ANTIGENS, CD3; IMMUNOTHERAPY, ADOPTIVE; MICE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 26044445767     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.08.013     Document Type: Note

References (34)

1. R. Billingham, L. Brent, and P. Medawar Quantitative studies on tissue transplantation immunity: the origin, strength and duration of actively and adoptively acquired immunity Proc. R. Soc. Biol. 143 1954 58 80
2. P. Moss, and A. Rickinson Cellular immunotherapy for viral infection after Hsc transplantation Nat. Rev., Immunol. 5 2005 9 20
3. C.H. June, Chapter 33: adoptive cellular therapies, in: B. Chabner, D.L. Longo, (Eds.), Cancer Chemotherapy and Biotherapy: Principles and Practice, Baltimore: Lippincott Williams and Wilkins, in press.
4. + T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation Clin. Cancer Res. 5 1999 461 469
5. M.V. Maus, A.K. Thomas, D.G.B. Leonard, et al., Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat. Biotechnol. 20 (2002) 143-148.
6. S. Shu, T. Chou, and S.A. Rosenberg In vitro sensitization and expansion with viable tumor cells and Il-2 in the generation of specific therapeutic effector cells J. Immunol. 136 1986 3891 3898
7. M. Sadelain, I. Riviere, and R. Brentjens Targeting tumours with genetically enhanced T lymphocytes Nat. Rev., Cancer 3 2003 35 45
8. G. Gross, T. Waks, and Z. Eshhar Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proc. Natl. Acad. Sci. U. S. A. 86 1989 10024 10028
9. W. Dummer, A.G. Niethammer, and R. Baccala T cell homeostatic proliferation elicits effective antitumor autoimmunity J. Clin. Invest. 110 2002 185 192
10. M.E. Dudley, J.R. Wunderlich, and J.C. Yang Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J. Clin. Oncol. 23 2005 2346 2357
11. A. Rapoport, E.A. Stadtmauer, N. Aqui et al. Combination immunotherapy consisting of vaccination and adoptive costimulated T cell transfer leads to rapid recovery of immunity following autotransplantation for myeloma. Nat. Med. (2005) in press.
12. K. Murali-Krishna, J.D. Altman, and M. Suresh Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection Immunity 8 1998 177 187
13. B.R. Gastman, D.E. Johnson, T.L. Whiteside, and H. Rabinowich Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events Blood 95 2000 2015 2023
14. M.A. Cheever, P.D. Greenberg, and A. Fefer Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with interleukin 2 J. Immunol. 126 1981 1318 1322
15. F.C. Garbrecht, C. Russo, and M.E. Weksler Long-term growth of human T cell lines and clones on anti-CD3 antibody-treated tissue culture plates J. Immunol. Methods 107 1988 137 142
16. B.D. Curti, D.L. Longo, and A.C. Ochoa Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2 J. Clin. Oncol. 11 1993 652 660
17. S.R. Riddell, and P.D. Greenberg The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells J. Immunol. Methods 128 1990 189 201
18. + T cells in the absence of exogenous feeder cells J. Immunol. 159 1997 5921 5930
19. W.A. Jensen, C.M. Pleiman, P. Beaufils, A.M. Wegener, B. Malissen, and J.C. Cambier Qualitatively distinct signaling through T cell antigen receptor subunits Eur. J. Immunol. 27 1997 707 716
20. + primary T cells Eur. J. Immunol. 24 1994 967 973
21. L.A. Pitcher, and N.S. Van Oers T-cell receptor signal transmission: who gives an ITAM? Trends Immunol. 24 2003 554 560
22. D. Patke, M. Ahmadzadeh, A.W. Bingaman, and D.L. Farber Anti-CD3 priming generates heterogenous antigen-specific memory CD4 T cells Clin. Immunol. 117 2005 125 132
23. E.L. Tham, and M.F. Mescher The poststimulation program of CD4 versus CD28 T cells (death versus activation-induced nonresponsiveness) J. Immunol. 169 2002 1822 1828
24. + effector and memory T cell generation Nat. Immunol. 4 2003 835 842
25. + splenic T cells after CD28 receptor ligation J. Immunol. 154 1995 985 997
26. + human mature T lymphocytes J. Biol. Chem. 279 2004 24485 24492
27. J.L. Riley, and C.H. June The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation Blood 105 2005 13 21
28. J.L. Cannons, P. Lau, and B. Ghumman 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy J. Immunol. 167 2001 1313 1324
29. + T cells confer superior antitumor immunity compared with effector memory T cells Proc. Natl. Aacad. Sci. 102 2005 9571 9576
30. + memory cell pool J. Clin. Invest. 115 2005 1177 1187
31. S. Roychowdhury, K.F. May Jr., and K.S. Tzou Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2 Cancer Res. 64 2004 8062 8067
32. Y. Li, M. Bleakley, and C. Yee IL-21 influences the frequency, phenotype, and affinity of the antigen specific CD8 T cell response J. Immunol. 175 2005 2261 2269
33. + T cell expansion and function J. Exp. Med. 201 2005 139 148
34. J.J. Sussman, R. Parihar, K. Winstead, and F.D. Finkelman Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion Cancer Res. 64 2004 9124 9130